|
Delayed
OTC Markets
23:06:37 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | - | - | - | - | - | 1 | |
| +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +105.71% | -14.63% | +243.04% | 53.03B | |
| -1.63% | -1.23% | +2.19% | +11.04% | +21.95% | +26.19% | +55.16% | +5.15% | +283.17% | 45.99B | |
| -1.15% | -3.25% | +1.25% | +13.03% | +21.74% | +17.47% | +98.19% | +3.39% | +1,012.67% | 42.45B | |
| -0.58% | +0.20% | -8.03% | +3.95% | +136.11% | +224.13% | +924.85% | +539.01% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| -0.32% | -1.68% | -10.56% | -5.15% | -7.39% | -14.70% | -5.46% | -68.37% | - | 22.1B | |
| +13.38% | +15.95% | -4.68% | +6.89% | -36.67% | -33.98% | +363.11% | +265.57% | +749.15% | 21.18B | |
| -1.78% | +4.16% | +9.49% | +16.45% | +21.28% | +16.52% | +181.70% | +200.66% | +2,247.17% | 19.38B | |
| +0.27% | +10.55% | +26.88% | +59.93% | +88.24% | +108.44% | +128.24% | -16.31% | +394.87% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -0.88% | +0.80% | +12.24% | +18.98% | +50.19% | +66.95% | +225.25% | +206.04% | +521.62% | 16.42B | |
| +0.67% | +3.08% | +9.83% | -0.62% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| +0.97% | +16.72% | +27.06% | +21.47% | +18.78% | +30.42% | -9.11% | -24.52% | +169.61% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.62% | +3.67% | +6.86% | +17.26% | +43.73% | +48.01% | +181.01% | +162.02% | +969.16% | 28.36B | |
| Weighted average by Cap. | +0.37% | +3.36% | +4.84% | +17.18% | +42.00% | +46.37% | +168.54% | +123.64% | +1,262.10% |
- Stock Market
- Stocks
- SEELQ Stock
- Sector Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
